Five Import-Risk Records That Belong in Separate Files
Good morning. Five records moved today, and they belong to different files rather than one enforcement push. They span tariff litigation, trade-remedy litigation, AD/CVD investigation activity, and Section 337 import-exclusion proceedings. Triage each one against the party, product, country, court, agency, or authority it actually touches.
The five records share a date, not a theme. They sit in separate operating files, a tariff class-certification fight, a Qatar melamine litigation step, a China CBS AD/CVD preliminary injury determination, and two Section 337 records covering dermatological treatment devices and TOPCon solar products.
This is a queue-discipline day. None of it warrants a broad policy alert, and each item warrants a targeted file check instead. Litigation teams update only the dockets where the named party or order matches. AD/CVD teams refresh investigation-stage assumptions. Section 337 teams check public-interest deadlines, respondent mapping, exclusion-order exposure, bonding, and CBP clearance implications.
Importers, counsel, and compliance teams should keep the workstreams apart. On AD/CVD, check investigation-stage duty assumptions, reserve posture, scope exposure, and landed-cost models where the product and country match. On Section 337, weigh exclusion-order exposure, respondent mapping, public-interest comment timing, bonding, and CBP clearance. On the tariff litigation, track whether class certification changes refund strategy, entry preservation, and client communications.
The next records are concrete. Court orders and briefing deadlines in the litigation files, public-interest comment deadlines on the newly filed Section 337 complaint, Commission action on institution, and any follow-on Commerce, CBP, USITC, or Federal Register notice tied to matters already in the file.
Don't overread today as a policy shift. The real risk is quieter. One court deadline, one record correction, or one notice can change a file a team is already managing.
USITC Preliminary Injury Determinations Keep CBS AD/CVD Investigations Moving
The USITC made affirmative preliminary injury determinations in investigations 701-TA-797 and 731-TA-1793 covering N-Cyclohexylbenzothiazole-2-Sulfenamide (CBS) from China, allowing Commerce's AD/CVD investigations to continue.
This is not yet an order or a final duty outcome, but it keeps potential AD/CVD exposure alive. Importers and counsel should refresh investigation-stage duty assumptions, sourcing quotes, reserve posture, and client updates where CBS from China is in the file.
USITC Receives Section 337 Complaint on Dermatological Treatment Devices II (DN 3918)
The USITC received a Section 337 complaint (DN 3918) concerning certain dermatological treatment devices and components thereof II. The complaint requests import remedies, including a limited exclusion order, cease and desist orders, and bonding during the Presidential review period.
This may affect import-exclusion risk, respondent mapping, public-interest comments, bonding exposure, and CBP clearance planning if the Commission institutes an investigation.
Paid review
Paid keeps the archive and source-backed exports available when a review needs to stay open.
See Paid pricing